Imports of drugs to Ukraine in 2022, after five years of growth, decreased by 38% compared to the previous year – to $ 1.9 billion from $ 3.1 billion.
This is evidenced by the research conducted by the marketing agency Top Lead together with the pharmaceutical company “Darnitsa”.
According to the study, the largest importers of medicines to Ukraine are Germany with the import volume of about $ 368 million, India ($ 173 million), France ($ 31 million), Italy ($ 125 million) and Slovenia ($ 110 million).
At the same time, export of Ukrainian medicines in 2022 decreased by 24% as compared with 2021, and amounted to $ 238 million.
The biggest buyer of Ukrainian medicines is Uzbekistan, where Ukrainian companies exported products worth almost $52m, which is 36% less than a year earlier.
At the same time, other top three buyers of Ukrainian medicines increased export – Kazakhstan by 12% (to $ 32 million), Lithuania – by 324% ($23 million).
“In 2022, Ukrainian companies stopped selling medicines to Russia and Belarus, export to Lithuania and Latvia increased. But despite this, most of the Ukrainian pharmaceutical export goes to Asia”, – report’s authors emphasize.
They also noted that, although the largest manufacturers of medicines in Ukraine have GMP-certificates issued by Gosleksluzhba, that confirm the production and control of drugs in accordance with international quality standards, the EU does not yet recognize these certificates. “Therefore, to export to the EU, a manufacturer has to undergo an additional check by the regulatory authorities of one or another EU country. The task for Ukraine in the near future is to achieve recognition of Ukrainian certificates in the EU,” the authors of the study stressed.
